Compugen, AstraZeneca reach 1st milestone in deal

By The Science Advisory Board staff writers

December 23, 2020 -- Compugen announced it is entitled to receive $2 million upon reaching the first preclinical milestone in an ongoing license agreement with AstraZeneca for the development of antibody products.

Under the deal, AstraZeneca received an exclusive license for the development of bispecific and multispecific antibody products based on one of Compugen's pipeline programs.

Compugen received a $10 million upfront payment and is eligible to receive up to $200 million in development, regulatory, and commercial milestones for the first product, as well as tiered royalties on future product sales, the company said.

Inovio to develop COVID-19 DNA-encoded monoclonal antibodies
Inovio, along with a team of scientists from the Wistar Institute, AstraZeneca, the University of Pennsylvania, and Indiana University, has received a...
AstraZeneca to test Russian Sputnik V vaccine
AstraZeneca said it will use one of the components of the Sputnik V vaccine, Russia's COVID-19 vaccine, in its own clinical trials for a COVID-19 vaccine....
AstraZeneca, partner for lung cancer diagnosis
AstraZeneca has partnered with deep-learning algorithm developer to integrate artificial intelligence solutions for the early detection of lung...
AstraZeneca COVID-19 vaccine achieves 70% efficacy
AstraZeneca released interim analysis from clinical trials of AZD1222, its COVID-19 vaccine candidate in the U.K. and Brazil, with data demonstrating...
Oxford/AstraZeneca COVID-19 vaccine strongly efficacious in older adults
Similar safety and immunogenicity profiles were observed in adults and older adults who received the Oxford/AstraZeneca SARS-CoV-2 vaccine candidate,...

Copyright © 2020

International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter